Healthcare Global Enterprises

583.30
+8.65
(1.51%)
Market Cap
8,132.10 Cr
EPS
3.46
PE Ratio
144.31
Dividend Yield
0.00 %
52 Week High
582.00
52 Week Low
330.65
PB Ratio
9.29
Debt to Equity
1.29
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+75.00 %
+75.00 %
Hold
Hold+25.00 %
+25.00 %
Sell
Sell0.0 %
0.0 %
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,074.10
#1 1,04,417.78
98.48
5,584.10
18.77
#1 1,058
-17.46
48.87
7,013.00
1,00,836.18
75.76
#1 19,165.50
14.74
917
49.14
67.35
650.00
49,072.28
64.05
6,931.20
8.99
645
#1 89.49
57.00
1,813.30
37,056.74
45.33
5,093.40
10.96
790
2.66
66.82
1,280.90
34,403.36
67.54
2,759.20
#1 25.09
326
15.71
59.81
646.85
25,882.99
72.52
2,511.20
12.94
336
20.76
59.67
498.00
24,875.75
93.24
3,723.70
22.85
205
-69.22
64.86
1,510.90
15,343.44
66.83
1,334.00
10.76
218
10.06
76.68
5,636.00
13,367.69
#1 29.61
599.90
11.69
58
8.85
53.98
1,434.30
9,404.13
49.27
1,095.50
21.32
177
20.14
38.77
Growth Rate
Revenue Growth
12.97 %
Net Income Growth
134.66 %
Cash Flow Change
13.11 %
ROE
135.47 %
ROCE
5.76 %
EBITDA Margin (Avg.)
-1.64 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
133
142
143
143
156
170
176
178
186
194
219
212
229
228
248
250
261
270
279
279
271
195
251
279
302
326
495
360
367
410
421
428
446
463
489
475
502
534
564
563
Expenses
115
123
127
125
131
144
149
150
153
162
180
180
191
198
213
222
231
228
238
234
236
176
218
245
343
272
292
342
302
336
345
349
365
386
402
391
403
435
451
470
EBITDA
19
19
17
18
25
26
28
28
34
32
39
32
38
30
34
28
30
43
42
45
35
19
33
34
-41
55
202
18
65
74
76
78
80
76
87
84
100
99
112
93
Operating Profit %
13 %
13 %
11 %
12 %
15 %
14 %
15 %
15 %
16 %
15 %
15 %
13 %
14 %
13 %
13 %
11 %
10 %
15 %
14 %
15 %
12 %
8 %
12 %
10 %
-16 %
16 %
17 %
4 %
17 %
18 %
18 %
18 %
17 %
16 %
17 %
17 %
18 %
17 %
18 %
16 %
Depreciation
10
11
11
11
12
13
14
15
15
15
17
18
21
20
21
22
23
34
35
38
42
39
40
42
38
38
38
41
41
40
41
41
42
41
43
44
46
47
50
57
Interest
9
9
9
10
11
5
6
5
7
7
10
10
15
18
24
13
16
31
35
36
36
37
27
29
26
26
23
24
24
25
26
27
26
26
27
30
27
34
36
41
Profit Before Tax
0
0
-1
-1
2
8
8
8
12
10
12
4
2
-8
-10
-7
-8
-23
-27
-28
-42
-57
-32
-35
-104
-9
142
-46
1
10
10
11
13
11
18
11
28
19
28
-3
Tax
0
-0
-1
1
-2
3
3
3
4
4
2
2
2
-1
-3
-1
3
-2
-2
1
9
-11
-5
-1
9
4
43
4
-1
8
5
7
8
7
7
8
5
5
7
-11
Net Profit
0
1
-1
-2
4
5
5
5
8
6
10
1
-0
-6
-8
-6
-11
-21
-25
-29
-50
-46
-27
-35
-114
-13
99
-50
2
3
5
4
6
4
11
3
24
14
21
8
EPS in ₹
-0.04
-0.07
-0.23
-0.30
0.44
0.59
0.58
0.63
0.90
0.55
1.17
0.37
0.30
-0.39
-0.74
-0.71
-0.99
-2.05
-2.51
-2.57
-4.91
-4.48
-1.94
-2.33
-8.14
-0.76
8.22
-3.55
0.43
0.44
0.53
0.54
0.60
0.55
0.97
0.41
1.53
0.87
1.29
0.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
776
1,034
1,226
1,444
1,654
2,253
2,036
2,220
2,316
2,708
Fixed Assets
529
568
685
828
970
1,646
1,382
1,547
1,553
1,758
Current Assets
122
201
244
220
273
304
435
502
580
680
Capital Work in Progress
42
155
148
174
153
46
30
22
18
83
Investments
0
60
11
53
49
34
26
9
10
10
Other Assets
205
252
382
389
482
527
597
642
735
856
Total Liabilities
776
1,034
1,226
1,444
1,654
2,253
2,036
2,220
2,316
2,708
Current Liabilities
187
195
366
359
547
576
465
470
570
744
Non Current Liabilities
284
270
371
506
584
1,258
856
866
876
1,099
Total Equity
305
569
490
579
522
420
714
884
869
865
Reserve & Surplus
209
451
347
398
389
293
528
731
721
687
Share Capital
70
85
86
87
88
89
125
139
139
139

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
3
85
-29
-24
-56
-30
62
190
-22
-5
Investing Activities
-79
-204
-210
-283
-238
-101
-171
125
-133
-226
Operating Activities
60
73
91
98
99
130
121
220
252
285
Financing Activities
22
216
89
161
84
-58
112
-155
-140
-64

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
70.71 %
68.41 %
68.40 %
71.44 %
71.43 %
71.42 %
71.39 %
71.38 %
71.37 %
71.35 %
71.30 %
71.29 %
71.28 %
71.25 %
71.23 %
71.23 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.28 %
0.00 %
6.74 %
3.95 %
4.29 %
2.77 %
DIIs
7.82 %
7.86 %
6.27 %
5.52 %
4.90 %
3.56 %
4.03 %
4.40 %
5.54 %
6.58 %
7.94 %
6.66 %
8.52 %
10.89 %
11.64 %
12.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.05 %
9.46 %
10.83 %
10.07 %
10.84 %
11.58 %
11.21 %
11.60 %
11.44 %
10.43 %
9.96 %
9.68 %
9.39 %
9.41 %
9.33 %
9.60 %
Others
14.42 %
14.26 %
14.50 %
12.97 %
12.83 %
13.44 %
13.38 %
12.61 %
11.65 %
11.63 %
4.52 %
12.37 %
4.07 %
4.49 %
3.50 %
3.46 %
No of Share Holders
13,891
15,065
20,573
22,362
23,663
23,018
24,672
28,707
28,858
25,931
27,327
27,289
27,195
26,529
29,670
32,820

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement Under Regulation 301 hour ago
Clarification sought from HealthCare Global Enterprises Ltd1 hour ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 29, 2025
Closure of Trading WindowMar 29, 2025
Cautionary E-Mail From BSE Limited Dated March 28 2025Mar 28, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 28, 2025
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 19, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 17, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 11, 2025
Draft Letter of OfferMar 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMar 06, 2025
Announcement Under Regulation 30 Of SEBI (LODR) RegulationsMar 03, 2025
Detailed Public StatementMar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 27, 2025
Disclosure under Regulation 30A of LODRFeb 25, 2025
Disclosure under Regulation 30A of LODRFeb 25, 2025
Integrated Filing (Financial)Feb 24, 2025
Public Announcement - Open OfferFeb 24, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferFeb 23, 2025
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferFeb 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 23, 2025
Announcement Under Regulation 30Feb 23, 2025
Announcement Under Regulation 30Feb 23, 2025
Announcement Under Regulation 30Feb 23, 2025
Announcement Under Regulation 30Feb 23, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Board Meeting Outcome for Disclosure Under Regulation 30Feb 23, 2025
Board Meeting Outcome for Disclosure Under Regulation 30Feb 23, 2025
Announcment Under Regulation 30- Rescheduling Of Earnings CallFeb 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 16, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 14, 2025
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Results- Financial Results For Decembe 31 2024Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 11, 2025
Update on board meetingFeb 11, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 07, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2025
Board Meeting Intimation for Intimation Of The Meeting Of The Board Of Directors Of Healthcare Global Enterprises LimitedFeb 05, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 10, 2025
Closure of Trading WindowDec 30, 2024

Technical Indicators

RSI(14)
Neutral
69.15
ATR(14)
Volatile
21.05
STOCH(9,6)
Neutral
58.79
STOCH RSI(14)
Neutral
52.94
MACD(12,26)
Bullish
2.77
ADX(14)
Weak Trend
16.38
UO(9)
Bearish
61.27
ROC(12)
Uptrend And Accelerating
8.72
WillR(14)
Overbought
-9.10